Top investors predict significant changes in healthcare by 2025, including increased court action over legislative changes, the sale of Illumina, and a resurgence in health tech mergers and IPOs. Dr. Oz is expected to lead CMS, making Medicare Advantage more accessible, while Apple is anticipated to revolutionize glucose monitoring with non-invasive technology. Health tech AI startups may struggle to sustain as standalone businesses, and cell therapy is predicted to regain prominence in treating solid tumors.
A CNN reporter wore a continuous glucose monitor (CGM) for six weeks to explore its use as a wellness tool for non-diabetics. The experience highlighted how CGMs, traditionally used by diabetics to manage insulin levels, are now marketed to the general public to provide insights into how food, exercise, and stress affect glucose levels. The reporter found that the device influenced her eating habits, sometimes causing anxiety about glucose spikes. Experts are divided on the benefits of CGMs for non-diabetics, with some advocating for their potential to improve health awareness and others cautioning against misuse without proper guidance.
The Lingo continuous glucose monitor (CGM) by Abbott offers a consumer-friendly way to track blood sugar levels, providing insights into metabolic health and potential diabetes risk. Unlike traditional CGMs requiring prescriptions, Lingo is FDA-cleared for general wellness use, allowing users to monitor how diet and lifestyle affect glucose levels. While the app provides useful health insights, some users may find its motivational language and features like the 'Lingo Count' less appealing. The device is currently only compatible with iPhones, and its affordability makes it a viable option for periodic health check-ins.
